Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03673098
Other study ID # 2018P001803
Secondary ID 5R34AT009170
Status Completed
Phase N/A
First received
Last updated
Start date November 5, 2018
Est. completion date April 14, 2021

Study information

Verified date May 2022
Source Massachusetts General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators refined and piloted the Relaxation Response Resiliency (3RP) intervention for women age 50 and over who are living with HIV, a group especially burdened by stressors related both to aging and to living with chronic disease. In this part of the study, the investigators will use data from the first phase to further adapt the intervention manual, and test the final product via a small randomized controlled trial in the same population.


Description:

Overview. This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators adapted an existing resiliency intervention, the Relaxation Response Resiliency Program (3RP), to the needs of women ages 50 and over who are living with HIV. The investigators conducted preliminary testing of the refined group intervention via an open pilot study (N=13 enrolled) across two sites, MGH and Boston Medical Center), and conducted individual exit interviews to solicit feedback on the intervention. Based on these qualitative data, as well as qualitative work conducted previously with this population, the goal of this phase of the project is to conduct a small, randomized pilot of the intervention in groups of up to 10 women with HIV (total N=up to 60) to assess feasibility and acceptability of all study procedures. Study Procedures. Participants will be women living with HIV (N=up to 60) age 50 or over, who are recruited via flyers and provider referral from Boston area hospitals and health care settings, as well as community organizations serving individuals living with HIV. Once an individual expresses interest in the study, they will be screened by a study staff member, either by phone or in person, in order to assess study eligibility. Eligible and interested individuals will be invited to sign informed consent and complete an in-person baseline assessment. Participants will be randomized to either a 10-week intervention group (adapted 3RP intervention) or a 10-week control group (supportive psychotherapy program). Participants will then complete a post-treatment assessment, an individual in-depth exit interview to provide feedback on their experience in the study, and a 3-month follow-up assessment. Data from this second phase of the study will inform the eventual development of a full-scale randomized controlled trial. Adapted 3RP Intervention. Once randomized into the intervention condition, participants will complete 10, 90-minute weekly group sessions of the adapted 3RP intervention. Sessions will focus on developing an understanding of stress sources and physiology, and on developing a regular practice of eliciting the relaxation response (RR) and learning cognitive behavioral and positive psychology skills to enhance resiliency to long-term stress. Participants will be encouraged to practice skills (RR practice, thoughts records to learn adaptive thinking) between group sessions. Supportive Psychotherapy Control Program. The control condition will be a supportive therapy program that is matched to the intervention for number and length of sessions. Basic principles of supportive psychotherapy will be followed, and the interventionist will facilitate discussion around what it is like to live with HIV as an aging woman.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date April 14, 2021
Est. primary completion date March 8, 2021
Accepts healthy volunteers No
Gender Female
Age group 50 Years and older
Eligibility Inclusion Criteria: - biologically born women who endorse a female identity - living with HIV/AIDS - age 50 or older - English-speaking Exclusion Criteria: - presence of an active (i.e. untreated) and interfering psychiatric disorder (e.g., bipolar disorder, schizophrenia, substance abuse) - have participated in a structured cognitive behavioral therapy and/or a mind-body intervention in the past year

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Adapted 3RP
The 3RP blends stress management principles, cognitive behavioral therapy, and positive psychology. The 3RP focuses on 3 major areas: (1) eliciting the relaxation response; (2) increasing stress awareness; and (3) promoting adaptive strategies. The adapted 3RP intervention consists of 10, 90-minute weekly group sessions. Content specific to older women living with HIV, including self-compassion exercises, was added to the intervention in the first phase of this study (open pilot).

Locations

Country Name City State
United States Massachusetts General Hospital Boston Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
Massachusetts General Hospital National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of Study Procedures, as Assessed by Number of Individuals Screened and Eligible for Participation in the Study Investigators assessed feasibility of study procedures by tracking the number of potential participants screened and eligible for participation. These metrics were assessed together with the number of eligible individuals enrolled, and the number of assessments completed in order to provide a comprehensive understanding of the feasibility of this study. Assessed at screening (pre-baseline)
Primary Feasibility of Study Procedures, as Assessed by Number of Individuals Enrolled and Number of Assessments and Sessions Completed by Enrolled Individuals. Investigators assessed feasibility of study procedures by tracking the number of eligible participants enrolled, and the number of treatment, assessment, and make-up sessions completed by all enrolled participants. These metrics were assessed together with the number of individuals screened and eligible in order to provide a comprehensive understanding of the feasibility of this study. Assessed up to 6 months post-baseline
Primary Feasibility of Study Procedures, as Assessed by Time Required for Screening and Enrollment Investigators assessed feasibility of study procedures by tracking the time it takes to screen and enroll participants, as measured by the number of months it took to recruit, screen, and schedule a baseline assessment for all 44 participants, compared to the number of months we estimated it would take to enroll our target number of participants at the outset of the study (11 months). These metrics were assessed in order to provide a comprehensive understanding of the feasibility of this study. Assessed after completion of all baseline assessments
Primary Feasibility of Study Procedures, as Assessed by Time Required to Complete Study Procedures Investigators assessed feasibility of study procedures by tracking the time it takes for participants to complete each assessment. These metrics were assessed in order to provide a comprehensive understanding of the feasibility of this study. Assessed up to 6 months post-baseline
Primary Feasibility as Assessed by Reasons for Declining Enrollment Includes the number of individuals who were eligible (N=61), but declined to enroll and those reasons for declining. Assessed at screening (pre-baseline)
Primary Feasibility as Assessed by Reasons for Enrolling But Not Taking Part in Group Sessions Includes the number of individuals who enrolled, but did not take part in group sessions (N=2) and the reasons for not participating. Assessed up to 3 months post-baseline
Primary Feasibility as Assessed by Reasons for Withdrawing From the Study Includes the number of individuals who withdrew from the study, despite participating in group sessions (N=7), and the reasons for withdrawing. Assessed up to 6 months post-baseline
Primary Feasibility as Assessed by Participants Lost to Follow-Up Includes the number of individuals who were lost to follow-up and unable to be traced (N=5). Assessed up to 6 months post-baseline
Primary Acceptability of Study Procedures, as Assessed by the Client Satisfaction Questionnaire Investigators assessed acceptability at the post-treatment visit using the eight-item Client Satisfaction Questionnaire (CSQ-8), a measure of how much an individual values a treatment. Items are summed to create an overall score; scores range from 8 to 32, with higher scores indicating higher satisfaction. Excellent acceptability was defined a priori as CSQ-8 scores between 26 and 32, and good acceptability was defined a priori as CSQ-8 scores between 20 and 25. Assessed up to 6 months post-baseline
Primary Acceptability of Study Procedures, as Assessed by the Perception of Study Assessments Questionnaire Investigators assessed acceptability at the post-treatment visit by asking participants about their perceptions of the burden of the study assessment battery on a scale from 1 ("no/minimal burden") to 10 ("too much of a burden"). Items are summed to create an overall score; scores range from 1 to 10, with lower scores indicating higher satisfaction. Assessed up to 6 months post-baseline
See also
  Status Clinical Trial Phase
Completed NCT03270943 - The S.M.A.R.T. Project: Stress Management and Resilience Training for Teens N/A
Terminated NCT04970641 - Three Good Things (3GT) - Intervention for Transitional Care Patients N/A
Completed NCT03308981 - Efficacy of the REThink Therapeutic Online Game N/A
Not yet recruiting NCT06061965 - Facilitating Advance Care Planning Discussions for People With Advance Cancer N/A
Active, not recruiting NCT05293431 - Promote Brain Resilience for the Coronavirus (COVID-19) Pandemic N/A
Recruiting NCT05072340 - Evaluation of Resilience Skills Enhancement (RISE) Training Among University Students N/A
Recruiting NCT05094115 - Enhancing Resiliency and Optimizing Readiness in Military Personnel N/A
Active, not recruiting NCT05719129 - The Lasting Change Study
Completed NCT03071887 - Resilience Intervention for Older, HIV-Infected Women N/A
Recruiting NCT05130879 - Building Resilience @ Work Training Among Healthcare Workers N/A
Active, not recruiting NCT03705208 - Youth First: A Longitudinal Impact Evaluation N/A
Completed NCT05703529 - Group-based Positive Psychotherapy in Psychological Resilience of Only-Child-Lost People N/A
Completed NCT02603133 - Web-based Implementation for the Science of Enhancing Resilience Study N/A
Completed NCT05133115 - Fostering Resilience in Adolescents at Risk. N/A
Recruiting NCT04935710 - Prevention and Early Identification for High Risk Youth in School-based Clinics Phase 1
Completed NCT04231604 - Evaluation of a School-based Programme Aimed at Promoting Well-being in Adolescents N/A
Enrolling by invitation NCT06021236 - Efficacy of a Mindfulness-Based Intervention in Patients With Cardiovascular Implantable Electronic Device N/A
Active, not recruiting NCT05648045 - Resilience and Obesity Prevention in Adolescents
Recruiting NCT03458936 - Resilience in Adolescent Development
Completed NCT05154565 - Effect of a Daily Meditation Intervention in Student Pharmacists N/A